Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nezam Afdhal

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Diagnostic Microbiology and Infectious Disease|December 22, 2023
Case report and mini-review: Sarcina ventriculi in the stomach of an 80-year-old femaleAndrea Kirmaier, Jeffrey Kubiak, Lily Mahler, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCVCamilla S Graham, Michael Curry, Qi He, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2012
Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infectionElliot B Tapper, Eric B Cohen, Keyur Patel, et al.
Digestive Diseases and Sciences|October 15, 2015
Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASHCarolina F M G Pimentel, Zhenghui G Jiang, Takeshi Otsubo, et al.
Plos One|October 11, 2019
Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trialVictor J Navarro, Steven H Belle, Massimo D'Amato, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
Progression of liver fibrosis among injection drug users with chronic hepatitis CLucy E Wilson, Michael Torbenson, Jacquie Astemborski, et al.
Clinical Trials (London, England)|November 8, 2011
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis CK Rajender Reddy, Steven H Belle, Michael W Fried, et al.
JAMA|July 17, 2012
Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trialMichael W Fried, Victor J Navarro, Nezam Afdhal, et al.
Journal of Medical Virology|March 18, 2017
SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variantsMeleri Jones, Morven E Cunningham, Peter Wing, et al.
Hepatology (Baltimore, Md.)|September 29, 2006
Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infectionRobert J Fontana, David E Kleiner, Richard Bilonick, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Diagnostic Microbiology and Infectious Disease|December 22, 2023
Case report and mini-review: Sarcina ventriculi in the stomach of an 80-year-old femaleAndrea Kirmaier, Jeffrey Kubiak, Lily Mahler, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCVCamilla S Graham, Michael Curry, Qi He, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2012
Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infectionElliot B Tapper, Eric B Cohen, Keyur Patel, et al.
Digestive Diseases and Sciences|October 15, 2015
Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASHCarolina F M G Pimentel, Zhenghui G Jiang, Takeshi Otsubo, et al.
Plos One|October 11, 2019
Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trialVictor J Navarro, Steven H Belle, Massimo D'Amato, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
Progression of liver fibrosis among injection drug users with chronic hepatitis CLucy E Wilson, Michael Torbenson, Jacquie Astemborski, et al.
Clinical Trials (London, England)|November 8, 2011
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis CK Rajender Reddy, Steven H Belle, Michael W Fried, et al.
JAMA|July 17, 2012
Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trialMichael W Fried, Victor J Navarro, Nezam Afdhal, et al.
Journal of Medical Virology|March 18, 2017
SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variantsMeleri Jones, Morven E Cunningham, Peter Wing, et al.
Hepatology (Baltimore, Md.)|September 29, 2006
Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infectionRobert J Fontana, David E Kleiner, Richard Bilonick, et al.
Pageof 8